ReviewFrontiers in oncology2022
LKB1: Can We Target an Hidden Target? Focus on NSCLC.
Gloriana Ndembe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ReviewFrontiers in oncology2022
Gloriana Ndembe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.